Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

0.5499 -0.0572 (-9.42%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist

Price and Volume

Volume	2,154,664
Open	0.5425
Bid (Size)	0.5500 (1,100)
Ask (Size)	0.5540 (800)
Prev. Close	0.6071
Today's Range	0.5330 - 0.5900
52wk Range	0.5040 - 109.80
Shares Outstanding	11,523,716
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

These stocks are moving in today's session ↗

December 26, 2025

Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Top movers in Friday's session ↗

December 26, 2025

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Via Chartmill

Performance

YTD	-99.4%	-99.4%
1 Month	-60.2%	-60.2%
3 Month	-61.8%	-61.8%
6 Month	-82.0%	-82.0%
1 Year	-99.4%	-99.4%

More News

Aptevo Therapeutics Stock Slumps To All-Time Low On Reverse Split Approval ↗

December 26, 2025

Via Stocktwits

Traders are paying attention to the gapping stocks in Friday's session. ↗

December 26, 2025

Via Chartmill

What's Going On With Aptevo Therapeutics Stock Today? ↗

December 26, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

December 26, 2025

Via Chartmill

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

December 26, 2025

Via ACCESS Newswire

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

December 09, 2025

Via ACCESS Newswire

Aptevo Debuts First Trispecific Antibody Candidate, APVO451, with Preclinical Data Demonstrating Immune Activation in Hard-to-Treat Solid Tumors

November 10, 2025

Via ACCESS Newswire

Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update

November 06, 2025

Via ACCESS Newswire

Aptevo Presenting Scientific and Clinical Updates at SITC and ASH, also Participating in Leading Financial and Industry Conferences in the Fourth Quarter

October 08, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 07, 2025

Via Benzinga

Which stocks are moving on Tuesday? ↗

October 07, 2025

Via Chartmill

Tuesday's session: gap up and gap down stocks ↗

October 07, 2025

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

October 07, 2025

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 07, 2025

Via Benzinga

Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket ↗

October 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 06, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

October 06, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 19, 2025

Via Benzinga

Top movers in Friday's pre-market session ↗

September 19, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 19, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

September 18, 2025

Via Chartmill

Most active stocks in Thursday's session ↗

September 18, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

September 18, 2025

Via Benzinga

Frequently Asked Questions

Is Aptevo Therapeutics Inc. - Common Stock publicly traded?

Yes, Aptevo Therapeutics Inc. - Common Stock is publicly traded.

What exchange does Aptevo Therapeutics Inc. - Common Stock trade on?

Aptevo Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aptevo Therapeutics Inc. - Common Stock?

The ticker symbol for Aptevo Therapeutics Inc. - Common Stock is APVO on the Nasdaq Stock Market

What is the current price of Aptevo Therapeutics Inc. - Common Stock?

The current price of Aptevo Therapeutics Inc. - Common Stock is 0.5499

When was Aptevo Therapeutics Inc. - Common Stock last traded?

The last trade of Aptevo Therapeutics Inc. - Common Stock was at 12/29/25 04:00 PM ET

What is the market capitalization of Aptevo Therapeutics Inc. - Common Stock?

The market capitalization of Aptevo Therapeutics Inc. - Common Stock is 6.34M

How many shares of Aptevo Therapeutics Inc. - Common Stock are outstanding?

Aptevo Therapeutics Inc. - Common Stock has 6M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.